 |
| Aranthan "AJ" Jones II |
Aranthan “AJ” Jones II, who was global head of public affairs for BCW, has joined Vanda Pharmaceuticals as chief corporate affairs and communications officer at the biopharmaceutical company.
Prior to joining BCW in 2018, Jones was chief of staff & chief policy & communications officer at W.K. Kellogg Foundation, head of worldwide government affairs at Gilead Sciences and healthcare practice chairman at Podesta Group.
Vanda also recruited Joakim Wijkstrom, a veteran of Perry Ellis, One Main Financial, TBWA Chiat Day and BBDO. for the chief marketing position.
Jones and Wijkstrom report to CEO Mihael H. Polymeropoulos.
Vanda, which is developing treatments for jet lag disorder and motion sickness, registered $107M in first-half revenues and $10.9M in profit.
Based in DC, the company's shares trade on the NASDAQ.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
